Search Within

Guenther Koehne

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (50)
  2. Journal Article (16)
Groups
  1. Bone Marrow Transplant (66)
  2. CTCR Scholars (66)
  3. Center for Hematologic Malignancies (66)
  4. Department of Medicine (66)
  5. Hematologic Malignancies, Division of (66)
  6. MSK Grad Students (66)

More Groups

People
  1. Sergio Giralt (63)
  2. Miguel-Angel Perales (56)
  3. Hugo Castro-Malaspina (52)
  4. Esperanza Papadopoulos (49)
  5. Doris Ponce (47)
  6. Juliet Barker (47)

More People

Years
  1. 2021 (1)
  2. 2020 (4)
  3. 2018 (5)
  4. 2017 (16)
  5. 2016 (13)
  6. 2015 (7)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (34)
  2. Blood (22)
  3. Bone Marrow Transplantation (7)
  4. Blood Advances (1)
  5. Leukemia and Lymphoma (1)
  6. Science Translational Medicine (1)
Publishers
  1. Elsevier Inc. (34)
  2. American Society of Hematology (23)
  3. Nature Publishing Group (7)
  4. American Association for the Advancement of Science (1)
  5. Taylor & Francis Group (1)

Results (66)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Journal Article

    Cho, C.; Hsu, M.; Barba, P.; Maloy, M. A.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Journal Article

    Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic stem cell transplantation as curative therapy for hematologic malignancies
    Journal Article

    Jakubowski, A. A.; Petrlik, E.; Maloy, M.; Hilden, P.; Papadopoulos, E.; Young, J. W.; Boulad, F.; Castro-Malaspina, H.; Tamari, R.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34(+) selected grafts for allogeneic hematopoietic cell transplantation
    Journal Article

    Barba, P.; Ratan, R.; Cho, C.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P. B.; Devlin, S.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M.; Giralt, S. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save